Publish in this journal
Journal Information
Vol. 54. Issue 1.
Pages 42 (January 2018)
Share
Share
Download PDF
More article options
Vol. 54. Issue 1.
Pages 42 (January 2018)
Clinical image
DOI: 10.1016/j.arbr.2017.06.004
Full text access
Myxoma or Lung Cancer?
¿Mixoma o cáncer de pulmón?
Visits
...
Cláudia Freitasa,
Corresponding author
claudiaasfreitas@gmail.com

Corresponding author.
, J. Pedro Lopesb, David Araújoa
a Serviço de Pneumologia, Centro Hospitalar São João, Porto, Portugal
b Serviço de Medicina Interna, Centro Hospitalar São João, Porto, Portuga
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text

The authors describe a case of an 82-year-old male, heavy smoker, with a 1-month history of several syncopal episodes that performed a transthoracic echocardiogram as an outpatient that showed a left atrial mass suggesting a myxoma. The patient was admitted for etiologic study. A full blood count showed normocytic and normochromic anemia.

A thoracic computer tomography showed a right hilar, heterogenic and vascular mass with 101mm×45mm invading the left atrium (Fig. 1). The mass obliterates the right pulmonary vein and involves the right pulmonary artery with obliteration of the segmental branches of the middle lobe and compression of the segmental branches of the right inferior lobe. The posterior side of the right atrium and the distal portion of the superior vena cava showed also signs of invasion. Multiple bilateral pulmonary nodules suggesting secondary lesions and multiple mediastinal adenopathies were found. There were no bone lesions suggesting bone metastasis.

Fig. 1.

Sagittal (A) and coronal (B) CT scan showing the pulmonary mass invading the left atrium. Axial CT (C) showing the right pulmonary artery involved by the mass and an unilateral large-volume pleural effusion.

*: pulmonary mass; arrow: right pulmonary artery; double arrow: right pleural effusion.

(0.24MB).

Although no malignant cells were found in the pleural fluid and pleural biopsy analysis, a stage IV lung cancer diagnosis was assumed by a multi-disciplinary lung cancer group. Due to the severity of the lesions and the high risk of procedure-related complications, the multi-disciplinary group considered that there was no benefit of invasive diagnostic or therapeutic procedures and a best care support was decided for this patient.1

Reference
[1]
S. Novello, et al.
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol, 27 (2016), pp. v1-v27
Copyright © 2017. SEPAR
Idiomas
Archivos de Bronconeumología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.